观察软肝化疒征丸干预肝纤维化的主要作用机制。
The main mechanism of the interfering effects of Ruanganhuazheng Pills (RP) on hepatic fibrosis was studied.
目的：探讨“从肝论治”高尿酸血症，拟定清肝化浊饮进行临床观察。
Objective:To observe the clinical effects of clearing liver and relieve turbity formula in treating hyperuricemia.
总结分析以清肝化瘀法为主治疗慢性粒细胞白血病5 2例的远期疗效。
To summarize and analyze curative effect on 52 cases of Chronic Myelogenous Leukemia (CML) by clearing away liver fire and dispersing blood stasis.
结果养阴柔肝化淤法能有效改善肝炎后肝硬化患者的纳差、胁痛、腹胀、乏力等临床症候（P<0.01）。
Results NYFLRC decoction had the effect of ameliorating clinical symptoms such as eating little, hypochondriac pain, fullness of abdomen, fatigue, et al (P<001).
结论软肝化坚颗粒可能通过降低C57小鼠肝组织pdgf - B的表达，进而减轻肝纤维化程度和肝组织损伤。
ConclusionRuangan Huajian granule may alleviate the degree of liver inflammation and fibrosis through reducing hepatic expression of PDGF-B in C57 mice with experimental hepatic fibrosis.
比较餐用鳖甲与药典法鳖甲对肝纤维化的预防和治疗作用。
Compare the preventive and protective effects on hepatization fibrosis of Carapax trimycis.
这将在肝纤维化治疗上给予我们新的启发，并给我们提供检验新的治疗方法的平台。
This will give us new insights for the treatment for liver fibrosis, and it will give us the platform to test new treatments.
肝星状细胞是一种与肝纤维化密切相关的主要的细胞种类，它在肝受到损伤时形成瘢痕组织。
HSCs are the major cell type involved in liver fibrosis, which is the formation of scar tissue in response to liver damage.
骨髓的血小板生成量降低可能是由于药物、毒素、或如再生障碍性贫血、肝纤维化、原发性恶性肿瘤或骨髓造血障碍。
Decreased production of platelets in the marrow may be caused by drugs, toxins, or by primary marrow disorders such as aplasia, fibrosis, or hematopoietic malignancy.
对于肝纤维化，目前除了肝脏移植外，没有其它有效的治疗方法。
There are really no effective therapies for liver fibrosis-there is only transplantation.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
硫酸乙酰肝素是肝磷脂的前体，是重要的抗凝剂，目前只能从血液中提取，从未成功合成提取过，它并不是蛋白质，而是一种富硫似糖的分子，经常参与糖基化反应。
This is a precursor to heparin, an important anti-clotting agent that has, at present, to be extracted from blood, rather than being synthesised. Heparan sulphate is not a protein.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
报告指出，得到的结果表明基因沉默可能是“一个有效的和更具体的治疗肝纤维化的方法”。
The results suggest that gene silencing may be "an efficient and more specific approach for therapy of liver fibrosis, " the report states.
国际肝病：除了肝星状细胞在肝纤维化发生中的重要作用，还有哪些机制参与了肝纤维化的发生？
International Hepatology: Besides the important role of hepatic stellate cell in liver fibrosis development, are there any other important mechanisms involving liver fibrosis development?
国际肝病：目前有肝纤维化治疗的指南吗，对于肝纤维化患者您是如何治疗的？
International Hepatology: Are there any guidelines for liver fibrosis therapy and how do you treat the patients with liver fibrosis in clinical practice?
在胰岛素抵抗的患者中经肝穿刺检查对纤维化无显著影响。
There was no influence of fibrosis stage on liver biopsy in the insulin-resistance development.
目的：探讨慢性病毒性肝炎肝静脉管径及多普勒频谱改变与肝组织病理纤维化程度的关系。
Objective: to analyse the correlation of hepatic vein diameter and Doppler waveform changes with liver histologic fibrosis in chronic liver hepatitis patients.
结论肝硬化患者肝组织质量与肝血流动力学、肝纤维化指标及病理分期有关。
Conclusion liver mass in patients with liver cirrhosis is related to hepatic hemodynamics, indices for liver fibrosis and liver pathology.
观察疏肝清脂汤治疗混合性肝病肝纤维化的临床疗效。
To observe the clinical effect of Sugan Qingzhi Decoction on mixed liver disease fibrosis.
目的探讨卡托普利对早期肝炎肝硬化肝纤维化指标的影响。
Objective to explore the influence of captopril on liver fibrosis index during early-stage viral liver cirrhosis.
动态观察上述指标的变化既可掌握患者病情的演变，也为抗肝纤维化药物的筛选奠定基础。
The dynamic changement of three markers may be used to predict the trends of diseases and select effective medicine treating hepatic fibrosis.
目的研究空腹血清总胆汁酸(TBA)与血清纤维化指标和肝组织病理关系。
Objective to study the correlation between total serum bile acid (TBA) and the liver histology.
正如本病例报告所示，可视化及量化不同肝区肝功能对于肝大部分切除术或肝段导向治疗至关重要。
The visualisation and quantification of possible regional differences in liver function can be crucial in large liver resections or segmental liver-directed treatments, as illustrated by our cases.
请您给我们介绍一下抗肝纤维化药物对于肝星状细胞的可能的作用机制？
Would you please give us a brief introduction on the possible strategies to target HSCs using anti-fibrotic agents?
《国际肝病》：您刚才介绍了新型抗肝纤维化靶点和药物的的最新进展。你能否再给我们的读者介绍一下您演讲的要点？
Hepatology Digest: you have just presented the latest developments in novel anti-fibrotic targets and agents. Could you introduce your key message to our readers?
结论超声积分及超声与血清肝纤维化指标联合应用对肝纤维化无创定量诊断有较高的价值。
Conclusions Ultrasonography quantitative scoring system, especially when it is combined with serum fibrosis markers, has a higher value in noninvasive quantitative diagnosis of hepatic fibrosis.
肝硬化是肝细胞坏死后，肝纤维化和肝细胞再生所致。
Ongoing liver damage with liver cell necrosis followed by fibrosis and hepatocyte regeneration results in cirrhosis.
目的：确定乙肝病毒载量的影响以及乙肝病毒感染的肾移植受者肝纤维化进程中宿主相关因素。
OBJECTIVES: To determine the influence of hepatitis B virus (HBV) viral load and host-related factors on the progression of hepatic fibrosis in hepatitis B virus-infected renal transplant recipients.
目的：确定乙肝病毒载量的影响以及乙肝病毒感染的肾移植受者肝纤维化进程中宿主相关因素。
OBJECTIVES: To determine the influence of hepatitis B virus (HBV) viral load and host-related factors on the progression of hepatic fibrosis in hepatitis B virus-infected renal transplant recipients.
应用推荐